Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001077048-08-000137
Filing Date
2008-07-16
Accepted
2008-07-15 20:31:36
Documents
6
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 gamma-10k_033108.htm 10-K 1267975
2 CERTIFICATION OF THE CEO PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT ex31-1.htm EX-31 13148
3 CERTIFICATION OF THE CFO PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT ex31-2.htm EX-31 13245
4 CERTIFICATION OF THE CEO PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT ex32-1.htm EX-32 6035
5 CERTIFICATION OF THE CFO PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT ex32-2.htm EX-32 6224
6 img1.jpg GRAPHIC 2579
  Complete submission text file 0001077048-08-000137.txt   1311915
Mailing Address 7477 WEST LAKE MEAD BLVD., SUITE 170 LAS VEGAS NV 89128
Business Address 7477 WEST LAKE MEAD BLVD., SUITE 170 LAS VEGAS NV 89128 651-204-2048
Gamma Pharmaceuticals Inc (Filer) CIK: 0000904146 (see all company filings)

EIN.: 721235452 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 033-61890 | Film No.: 08954023
SIC: 2834 Pharmaceutical Preparations